Does ARIPIPRAZOLE Cause Hyperprolactinaemia? 459 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 459 reports of Hyperprolactinaemia have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.7% of all adverse event reports for ARIPIPRAZOLE.
459
Reports of Hyperprolactinaemia with ARIPIPRAZOLE
0.7%
of all ARIPIPRAZOLE reports
2
Deaths
92
Hospitalizations
How Dangerous Is Hyperprolactinaemia From ARIPIPRAZOLE?
Of the 459 reports, 2 (0.4%) resulted in death, 92 (20.0%) required hospitalization, and 8 (1.7%) were considered life-threatening.
Is Hyperprolactinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 459 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Hyperprolactinaemia?
RISPERIDONE (4,124)
PALIPERIDONE (1,427)
OLANZAPINE (520)
QUETIAPINE (331)
HALOPERIDOL (214)
CLOZAPINE (157)
AMISULPRIDE (135)
SERTRALINE (120)
LITHIUM (76)
VENLAFAXINE (71)
Which ARIPIPRAZOLE Alternatives Have Lower Hyperprolactinaemia Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE